Chronic Myeloproliferative Disorder With T(8;22)(P11;Q11) Can Mime Clonal Cytogenetic Evolution Of Authentic Chronic Myelogeneous Leukemia

Genes, Chromosomes and CancerVolume 47, Issue 10 p. 915-918 Letter to the Editors Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia Steven Richebourg, Corresponding Author Steven Richebourg Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, FranceLaboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, Avenue Eugène Avinée, 59037 Lille cedex, FranceSearch for more papers by this authorOlivier Theisen, Olivier Theisen Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, FranceSearch for more papers by this authorIsabelle Plantier, Isabelle Plantier Service d'Hématologie Clinique, CH de Roubaix, FranceSearch for more papers by this authorAnne Parry, Anne Parry Service d'Hématologie Clinique, CH de Roubaix, FranceSearch for more papers by this authorValérie Soenen-Cornu, Valérie Soenen-Cornu Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorPascale Lepelley, Pascale Lepelley Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorClaude Preudhomme, Claude Preudhomme Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorAline Renneville, Aline Renneville Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, FranceSearch for more papers by this authorJean-Luc Laï, Jean-Luc Laï Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorCatherine Roche-Lestienne, Catherine Roche-Lestienne Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this author Steven Richebourg, Corresponding Author Steven Richebourg Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, FranceLaboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, Avenue Eugène Avinée, 59037 Lille cedex, FranceSearch for more papers by this authorOlivier Theisen, Olivier Theisen Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, FranceSearch for more papers by this authorIsabelle Plantier, Isabelle Plantier Service d'Hématologie Clinique, CH de Roubaix, FranceSearch for more papers by this authorAnne Parry, Anne Parry Service d'Hématologie Clinique, CH de Roubaix, FranceSearch for more papers by this authorValérie Soenen-Cornu, Valérie Soenen-Cornu Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorPascale Lepelley, Pascale Lepelley Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorClaude Preudhomme, Claude Preudhomme Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorAline Renneville, Aline Renneville Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, FranceSearch for more papers by this authorJean-Luc Laï, Jean-Luc Laï Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this authorCatherine Roche-Lestienne, Catherine Roche-Lestienne Laboratoire de Génétique Médicale, Hôpital Jeanne de Flandre, CHRU de Lille, France Institut de Recherche sur le Cancer, Centre JP Aubert, Unité Inserm, Lille, FranceSearch for more papers by this author First published: 09 July 2008 https://doi.org/10.1002/gcc.20588Citations: 22Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Agerstam H,Lilljebjörn H,Lassen C,Swedin A,Richter J,Vandenberghe P,Johansson B,Fioretos T. 2007. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 46: 635–643. Cross NC,Reiter A. 2002. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 16: 1207–1212. Cuenco GM,Ren R. 2001. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukaemia. Oncogene 20: 8236–8248. Cuenco GM,Ren R. 2004. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice. Oncogene 23: 569–579. De Braekeleer E,Douet-Guilbert N,Le Bris MJ,Morel F,De Braekeleer M. 2007. Translocation 3;21, trisomy 8, and duplication of the Philadelphia chromosome: A rare but recurrent cytogenetic pathway in the blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 179: 159–161. Demiroglu A,Steer EJ,Heath C,Taylor K,Bentley M,Allen SL,Koduru P,Brody JP,Hawson G,Rodwell R,Doody ML,Carnicero F,Reiter A,Goldman JM,Melo JV,Cross NC. 2001. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: Transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 98: 3778–3783. Fioretos T,Panagopoulos I,Lassen C,Swedin A,Billström R,Isaksson M,Strömbeck B,Olofsson T,Mitelman F,Johansson B. 2001. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 32: 302–310. Johansson B,Fioretos T,Mitelman F. 2002. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107: 76–94. Macdonald D,Cross NC. 2007. Chronic myeloproliferative disorders: The role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 74: 81–88. Macdonald D,Reiter A,Cross NC. 2002. The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 107: 101–107. Mitani K,Ogawa S,Tanaka T,Miyoshi H,Kurokawa M,Mano H,Yazaki Y,Ohki M,Hirai H. 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13: 504–510. Murati A,Arnoulet C,Lafage-Pochitaloff M,Adélaide J,Derré M,Slama B,Delaval B,Popovici C,Vey N,Xerri L,Mozziconacci MJ,Boulat O,Sainty D,Birnbaum D,Chaffanet M. 2005. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol 26: 1485–1492. Phan CL,Megat Baharuddin PJ,Chin LP,Zakaria Z,Yegappan S,Sathar J,Tan SM,Purushothaman V,Chang KM. 2008. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia. Cancer Genet Cytogenet 180: 60–64. Pini M,Gottardi E,Scaravaglio P,Giugliano E,Libener R,Baraldi A,Muzio A,Cornaglia E,Saglio G,Levis A. 2002. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J 3: 315–316. Radich JP. The biology of CML blast crisis. 2007. Hematol Am Soc Hematol Edu Program 2007: 384–391. Roche-Lestienne C,Deluche L,Corm S,Tigaud I,Joha S,Philippe N,Geffroy S,Laï JL,Nicolini FE,Preudhomme C; on behalf of the Fi-LMC group. 2008. RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance. Blood 111: 3735–3741. Roumiantsev S,Krause DS,Neumann CA,Dimitri CA,Asiedu F,Cross NC,Van Etten RA. 2004. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 5: 287–298. Schoch C,Haferlach T,Kern W,Schnittger S,Berger U,Hehlmann R,Hiddemann W,Hochhaus A. 2003. Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia 17: 461–463. Wong WS,Cheng KC,Lau KM,Chan NP,Shing MM,Cheng SH,Chik KW,Li CK,Ng MH. 2007. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: A review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res 31: 235–238. Citing Literature Volume47, Issue10October 2008Pages 915-918 ReferencesRelatedInformation